Shanghai Haohai Biological Technology to Join Second-Half 2026 Industry Earnings Call on STAR Market

Deep News
Sep 07

Shanghai Haohai Biological Technology Co., Ltd. has officially confirmed its participation in an upcoming collective earnings communication session tailored for the biopharmaceutical and CXO sectors on the STAR Market.

The company announced on September 7 that the event, organized by the Shanghai Stock Exchange, is scheduled to take place from 15:00 to 17:00 on September 15, 2026.

This session is designed to provide a platform for listed firms to discuss their semi-annual performance results for 2026, fostering transparency and engagement with investors and market participants across the industry.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10